CA3255620A1 - ZINC FINGER DEGRON SEQUENCES - Google Patents

ZINC FINGER DEGRON SEQUENCES

Info

Publication number
CA3255620A1
CA3255620A1 CA3255620A CA3255620A CA3255620A1 CA 3255620 A1 CA3255620 A1 CA 3255620A1 CA 3255620 A CA3255620 A CA 3255620A CA 3255620 A CA3255620 A CA 3255620A CA 3255620 A1 CA3255620 A1 CA 3255620A1
Authority
CA
Canada
Prior art keywords
zinc finger
finger domain
hybrid
amino acid
cys2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3255620A
Other languages
English (en)
French (fr)
Inventor
Ali Can Sahillioglu
Antonius Nicolaas Maria Schumacher
Original Assignee
Netherlands Cancer Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Netherlands Cancer Institute filed Critical Netherlands Cancer Institute
Publication of CA3255620A1 publication Critical patent/CA3255620A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/95—Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA3255620A 2022-03-18 2023-03-17 ZINC FINGER DEGRON SEQUENCES Pending CA3255620A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL2031325 2022-03-18
NL2031325A NL2031325B1 (en) 2022-03-18 2022-03-18 Novel zinc finger degron sequences
PCT/NL2023/050136 WO2023177296A1 (en) 2022-03-18 2023-03-17 Zinc finger degron sequences

Publications (1)

Publication Number Publication Date
CA3255620A1 true CA3255620A1 (en) 2023-09-21

Family

ID=82483007

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3255620A Pending CA3255620A1 (en) 2022-03-18 2023-03-17 ZINC FINGER DEGRON SEQUENCES

Country Status (9)

Country Link
US (1) US20250206789A1 (https=)
EP (1) EP4493696A1 (https=)
JP (1) JP2025509853A (https=)
CN (1) CN118922547A (https=)
AU (1) AU2023233426A1 (https=)
CA (1) CA3255620A1 (https=)
IL (1) IL315649A (https=)
NL (1) NL2031325B1 (https=)
WO (1) WO2023177296A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2033636B1 (en) 2022-11-29 2024-06-04 Stichting Het Nederlands Kanker Inst Antoni Van Leeuwenhoek Ziekenhuis Receptor- and drug-dependent regulated on-site production of biologicals.
NL2037809B1 (en) 2024-05-29 2025-12-12 Cell Control Biotherapeutics Inc Loop reinforcement expression system for improved cell therapy products

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201710620D0 (en) 2017-07-03 2017-08-16 Glaxosmithkline Intellectual Property Ltd Targeted protein degradation
US12049482B2 (en) 2017-10-31 2024-07-30 The Brigham And Women's Hospital, Inc. Molecular switch-mediated control of engineered cells
WO2020132039A2 (en) 2018-12-18 2020-06-25 Dana-Farber Cancer Institute, Inc. Peptide tags for ligand induced degradation of fusion proteins
CN111907552B (zh) 2019-07-17 2021-08-13 中车大同电力机车有限公司 机车牵引装置及其调整方法
EP4048301B1 (en) 2019-10-23 2024-09-18 Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis Chimeric polypeptide for regulating immune cells
US20230151342A1 (en) 2020-02-28 2023-05-18 The Broad Institute, Inc Zinc finger degradation domains

Also Published As

Publication number Publication date
EP4493696A1 (en) 2025-01-22
NL2031325B1 (en) 2023-09-29
US20250206789A1 (en) 2025-06-26
CN118922547A (zh) 2024-11-08
WO2023177296A1 (en) 2023-09-21
AU2023233426A1 (en) 2024-10-31
JP2025509853A (ja) 2025-04-11
IL315649A (en) 2024-11-01

Similar Documents

Publication Publication Date Title
TWI908706B (zh) ＣＡＲＴｙｒｉｎ組成物和使用方法
TWI905076B (zh) 非複製勝任型重組反轉錄病毒顆粒及其用途
JP2022002530A (ja) ウイルスベクター効率を改善するための組成物及び方法
RU2757058C2 (ru) Индуцируемые каспазы и способы использования
AU2014364949B2 (en) Single chain IL-12 nucleic acids, polypeptides, and uses thereof
CN111727256A (zh) 用于嵌合配体受体（clr）-介导的条件性基因表达的组合物和方法
TW201809271A (zh) 用於轉導淋巴球及調節其活性之方法及組合物
KR20160015195A (ko) 인간화 항-EGFRvIII 키메라 항원 수용체를 사용한 암의 치료
US20250206789A1 (en) Zinc finger degron sequences
CN113710693B (zh) Dna结合结构域反式激活因子及其用途
JP2022514465A (ja) 第ｉｘ因子を発現するレンチウイルスベクターの使用
US20190224337A1 (en) Inducible expression cassette, and uses thereof
Henzi et al. Soluble dimeric prion protein ligand activates Adgrg6 receptor but does not rescue early signs of demyelination in PrP-deficient mice
JP7848138B2 (ja) 改変型上皮成長因子受容体及び細胞追跡におけるその使用
KR20230056706A (ko) 재조합 형질전환 성장 인자(tgf)-베타 단량체를 암호화하는 종양용해 바이러스 및 이의 용도
TW202221119A (zh) Dna結合域轉活化子及其用途
US20250361284A1 (en) Transposase fusion proteins for use in cell and gene therapy
WO2024117904A1 (en) Receptor- and drug-dependent regulated on-site production of biologicals
HK40086533A (zh) 编码重组转化生长因子(TGF)-β单体的溶瘤病毒及其用途
Chou Regulation of durable adaptive immune response by the c-MYC-AP4 transcriptional cascade
HK40023885A (en) Cd19 compositions and methods for immunotherapy

Legal Events

Date Code Title Description
A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A00-A101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION RECEIVED - PCT

Effective date: 20240917

A15 Pct application entered into the national or regional phase

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A15-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: NATIONAL ENTRY REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250211

P18 Priority claim added or amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P105 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIORITY CLAIM REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250211

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250218

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD

Year of fee payment: 2

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250310

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250310

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250310

A00 Application filed

Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A00-A102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: COMPLIANCE REQUIREMENTS DETERMINED MET

Effective date: 20250319

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P13-P146 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: BSL VERIFIED - NO DEFECTS

Effective date: 20250319

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260309

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260309